Details of Protein
General Information of Protein (ID: PRT00205) | |||||
---|---|---|---|---|---|
Name | Cystathionine gamma-lyase (CTH) | ||||
Synonyms |
Click to Show/Hide Synonyms of This Protein
Cysteine-protein sulfhydrase; Gamma-cystathionase; Cth
|
||||
Gene Name | Cth | Gene ID | |||
UniProt ID | |||||
Family | Lyases (EC 4) | ||||
EC Number | EC: 4.4.1.1 (Click to Show/Hide the Complete EC Tree) | ||||
Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
Sequence |
MQKDASLSGFLPSFQHFATQAIHVGQEPEQWNSRAVVLPISLATTFKQDFPGQSSGFEYS
RSGNPTRNCLEKAVAALDGAKHSLAFASGLAATITITHLLKAGDEIICMDEVYGGTNRYF RRVASEFGLKISFVDCSKTKLLEAAITPQTKLVWIETPTNPTLKLADIGACAQIVHKRGD IILVVDNTFMSAYFQRPLALGADICMCSATKYMNGHSDVVMGLVSVNSDDLNSRLRFLQN SLGAVPSPFDCYLCCRGLKTLQVRMEKHFKNGMAVARFLETNPRVEKVVYPGLPSHPQHE LAKRQCSGCPGMVSFYIKGALQHAKAFLKNLKLFTLAESLGGYESLAELPAIMTHASVPE KDRATLGINDTLIRLSVGLEDEQDLLEDLDRALKAAHP |
||||
Function | Catalyzes the last step in the trans-sulfuration pathway from methionine to cysteine. Has broad substrate specificity. Converts cystathionine to cysteine, ammonia and 2-oxobutanoate. Converts two cysteine molecules to lanthionine and hydrogen sulfide. Can also accept homocysteine as substrate. Specificity depends on the levels of the endogenous substrates. Generates the endogenous signaling molecule hydrogen sulfide (H2S), and so contributes to the regulation of blood pressure. Acts as a cysteine-protein sulfhydrase by mediating sulfhydration of target proteins: sulfhydration consists of converting -SH groups into -SSH on specific cysteine residues of target proteins such as GAPDH, PTPN1 and NF-kappa-B subunit RELA, thereby regulating their function. | ||||
Regulatory Network | |||||
Full List of Metabolite(s) Regulated by This Protein | ||||||
---|---|---|---|---|---|---|
Nucleosides, nucleotides, and analogues | ||||||
UDP-N-acetylglucosamine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | UDP-N-acetylglucosamine concentration: increase (FC = 2.17) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the increase of UDP-N-acetylglucosamine levels compared with control group. | |||||
Uridine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | Uridine concentration: increase (FC = 2.61) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the increase of uridine levels compared with control group. | |||||
Xanthosine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | Xanthosine concentration: increase (FC = 3.08) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the increase of xanthosine levels compared with control group. | |||||
Benzenoids | ||||||
m-Chlorohippuric acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | m-Chlorohippuric acid concentration: decrease (FC = 0.38) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the decrease of m-chlorohippuric acid levels compared with control group. | |||||
Lipids and lipid-like molecules | ||||||
9-OxoODE | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | 9-OxoODE concentration: increase (FC = 2.09) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the increase of 9-OxoODE levels compared with control group. | |||||
Cholesterol sulfate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | Cholesterol sulfate concentration: decrease (FC = 0.40) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the decrease of cholesterol sulfate levels compared with control group. | |||||
LysoPC(0:0/18:1(9Z)) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | LysoPC(0:0/18:1(9Z)) concentration: increase (FC = 2.85) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the increase of lysoPC(0:0/18:1(9Z)) levels compared with control group. | |||||
PC(16:0/16:0) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | PC(16:0/16:0) concentration: increase (FC = 2.07) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the increase of PC(16:0/16:0) levels compared with control group. | |||||
Organic acids and derivatives | ||||||
3-Hydroxybutyric acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | 3-Hydroxybutyric acid concentration: decrease (FC = 0.39) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the decrease of 3-hydroxybutyric acid levels compared with control group. | |||||
Arginine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | Arginine concentration: increase (FC = 2.65) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the increase of arginine levels compared with control group. | |||||
Betaine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | Betaine concentration: decrease (FC = 0.30) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the decrease of betaine levels compared with control group. | |||||
Citrulline | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | Citrulline concentration: increase (FC = 2.74) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the increase of citrulline levels compared with control group. | |||||
D-Aspartic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | D-Aspartic acid concentration: increase (FC = 2.10) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the increase of D-aspartic acid levels compared with control group. | |||||
Indoxyl sulfate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | Indoxyl sulfate concentration: increase (FC = 3.16) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the increase of indoxyl sulfate levels compared with control group. | |||||
Phenylacetylglycine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | Phenylacetylglycine concentration: increase (FC = 4.63) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the increase of phenylacetylglycine levels compared with control group. | |||||
S-Lactoylglutathione | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | S-Lactoylglutathione concentration: increase (FC = 3.89) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the increase of s-lactoylglutathione levels compared with control group. | |||||
Organic nitrogen compounds | ||||||
1-Methylhistamine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | 1-Methylhistamine concentration: increase (FC = 2.66) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the increase of 1-methylhistamine levels compared with control group. | |||||
Diethanolamine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | Diethanolamine concentration: decrease (FC = 0.39) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the decrease of diethanolamine levels compared with control group. | |||||
Organic oxygen compounds | ||||||
2,3-Bisphosphoglycerate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | 2,3-Bisphosphoglycerate concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the increase of 2,3-bisphosphoglycerate levels compared with control group. | |||||
Fructose 6-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | Fructose 6-phosphate concentration: increase (FC = 2.30) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the increase of fructose 6-phosphate levels compared with control group. | |||||
L-Arabinose | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | L-Arabinose concentration: decrease (FC = 0.48) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the decrease of L-Arabinose levels compared with control group. | |||||
N-Acetylneuraminic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | N-Acetylneuraminic acid concentration: increase (FC = 2.05) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the increase of N-acetylneuraminic acid levels compared with control group. | |||||
Pectin | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | Pectin concentration: decrease (FC = 0.50) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the decrease of pectin levels compared with control group. | |||||
Organoheterocyclic compounds | ||||||
1,3-Dihydro-(2H)-indol-2-one | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | 1,3-Dihydro-(2H)-indol-2-one concentration: increase (FC = 2.72) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the increase of 1,3-dihydro-(2H)-indol-2-one levels compared with control group. | |||||
L-Arabinono-1,4-lactone | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | L-Arabinono-1,4-lactone concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the decrease of L-Arabinono-1,4-lactone levels compared with control group. | |||||
Pyridoxamine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | Pyridoxamine concentration: increase (FC = 2.91) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the increase of pyridoxamine levels compared with control group. | |||||
Uracil | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | Uracil concentration: increase (FC = 2.80) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the increase of uracil levels compared with control group. | |||||
Xanthine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Cth | |||||
Induced Change | Xanthine concentration: increase (FC = 4.17) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
Details | It is reported that knockout of Cth leads to the increase of xanthine levels compared with control group. | |||||
References | |||||
---|---|---|---|---|---|
1 | Hydrogen Sulfide Is a Regulator of Hemoglobin Oxygen-Carrying Capacity via Controlling 2,3-BPG Production in Erythrocytes. Oxid Med Cell Longev. 2021 Feb 13;2021:8877691. |
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.